Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$32.7K Buy
794
+16
+2% +$605 ﹤0.01% 1489
2026
Q1
$27.8K Buy
778
+3
+0.4% +$109 ﹤0.01% 1481
2025
Q4
$25.1K Buy
775
+633
+446% +$19.8K ﹤0.01% 1477
2025
Q3
$4.01K Buy
142
+98
+223% +$2.81K ﹤0.01% 1930
2025
Q2
$1.33K Buy
44
+10
+29% +$339 ﹤0.01% 2039
2025
Q1
$1.39K Sell
34
-16
-32% -$769 ﹤0.01% 2010
2024
Q4
$2.71K Buy
50
+44
+733% +$2.52K ﹤0.01% 1877
2024
Q3
$390 Buy
+6
New +$385 ﹤0.01% 2111
2024
Q2
Sell
-15
Closed -$1.27K 2155
2024
Q1
$1.27K Buy
+15
New +$1.19K ﹤0.01% 1694
2022
Q2
Sell
-5
Closed 1916
2022
Q1
$0 Sell
5
-5
-50% -$470 ﹤0.01% 1991
2021
Q4
$1K Buy
+10
New +$1.02K ﹤0.01% 1899

Other funds holding CRI

UMB Bank's CRI Position: Q2 2026 in Review

UMB Bank increased its Carter's (CRI) stake by 2.1% in Q2 2026, buying an estimated $605 and bringing the position to 794 shares worth $32.7K. The position accounts for ﹤0.01% of the portfolio, ranked #1489.

UMB Bank first reported a position in CRI in Q4 2021 and has held it in 11 quarters since. 287 funds tracked by Wall St. Rank hold CRI as of Q2 2026.

  • UMB Bank held 794 shares of Carter's worth $32.7K as of Q2 2026.
  • UMB Bank bought 16 Carter's shares in Q2 2026, an estimated $605.
  • Carter's made up ﹤0.01% of UMB Bank's portfolio in Q2 2026, its #1489 holding.
  • UMB Bank first reported a position in Carter's in Q4 2021 and has held it in 11 quarters since.
  • 287 funds tracked by Wall St. Rank held Carter's as of Q2 2026.

Based on UMB Bank's 13F filing for Q2 2026, filed 13 Aug 2026.